CRISPR Trial Provides Hope for Inherited Blindness
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
Source: neurosciencenews.com
Stay updated with breaking news from Stevent Bailey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures. CRISPR-based therapy
The following cases were adjudicated, reviewed or continued in Hancock County Court, according to official records: